Joseph Todisco - 12 Jan 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Chief Executive Officer, Director
Signature
/s/ Beth Zelnick Kaufman, attorney-in-fact
Issuer symbol
CRMD
Transactions as of
12 Jan 2026
Net transactions value
-$178,203
Form type
4
Filing time
20 Jan 2026, 09:28:12 UTC
Previous filing
19 Dec 2025
Next filing
27 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Todisco Joseph Chief Executive Officer, Director C/O CORMEDIX INC., 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS /s/ Beth Zelnick Kaufman, attorney-in-fact 20 Jan 2026 0001774807

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Tax liability $124,532 -17,417 -3.4% $7.15 492,079 12 Jan 2026 Direct F1
transaction CRMD Common Stock Options Exercise $99,997 +29,585 +6% $3.38 521,664 16 Jan 2026 Direct F2
transaction CRMD Common Stock Tax liability $153,669 -22,665 -4.3% $6.78 498,999 17 Jan 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -29,585 -6.7% $0.000000 411,245 16 Jan 2026 Common Stock 29,585 $3.38 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is being reported late due to an inadvertent administrative error.
F2 The Reporting Person acquired stock through the exercise of options granted on 5/10/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made.
F3 These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney